27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

ELEV Insider Trading (Elevation Oncology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,895,276.44

Elevation Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at Elevation Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevation Oncology Share Price & Price History

Current Price: $1.40
Price Change: Price Decrease of -0.08 (-5.41%)
As of 06/30/2022 01:00 AM ET

This chart shows the closing price history over time for ELEV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Elevation Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2022Global Strategic Fund I VenbioMajor ShareholderSell702,737$4.12$2,895,276.441,905,430View SEC Filing Icon  
See Full Table
The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>

SEC Filings (Institutional Ownership Changes) for Elevation Oncology (NASDAQ:ELEV)

95.78% of Elevation Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELEV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Elevation Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC25,400$64K0.0%+53.0%0.109%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.376,153$0.95M0.0%-1.2%1.618%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.38,218$96K0.0%+57.4%0.164%Search for SEC Filing on Google Icon
4/26/2022Marquette Asset Management LLC38,951$98K0.0%+332.5%0.168%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.23,500$59K0.0%N/A0.101%Search for SEC Filing on Google Icon
2/18/2022TCG Crossover Management LLC555,000$3.34M1.6%N/A2.389%Search for SEC Filing on Google Icon
2/15/2022Kennedy Capital Management Inc.15,485$93K0.0%N/A0.067%Search for SEC Filing on Google Icon
2/14/2022Boxer Capital LLC872,780$5.25M0.2%-34.9%3.758%Search for SEC Filing on Google Icon
2/14/2022Sio Capital Management LLC250,000$1.51M0.5%N/A1.076%Search for SEC Filing on Google Icon
1/19/2022Marquette Asset Management LLC9,006$54K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC18,044$0.14M0.0%-29.8%0.078%Search for SEC Filing on Google Icon
11/16/2021Janus Henderson Group PLC1,220,205$9.38M0.0%+18.3%5.254%Search for SEC Filing on Google Icon
11/16/2021Caxton Corp48,183$0.38M0.3%+21.7%0.207%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.23,837$0.19M0.0%N/A0.103%Search for SEC Filing on Google Icon
8/17/2021Weiss Multi Strategy Advisers LLC15,037$0.20M0.0%N/A0.066%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP112,431$1.53M0.0%N/A0.493%Search for SEC Filing on Google Icon
8/17/2021Samsara BioCapital LLC932,239$12.65M1.6%N/A4.085%Search for SEC Filing on Google Icon
8/17/2021Sphera Funds Management LTD.30,000$0.41M0.0%N/A0.131%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC123,062$1.67M0.0%N/A0.539%Search for SEC Filing on Google Icon
8/17/2021BVF Inc. IL1,590,291$21.58M0.8%N/A6.968%Search for SEC Filing on Google Icon
8/17/2021Boxer Capital LLC1,341,530$18.21M0.6%N/A5.878%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP60,000$0.81M0.0%N/A0.263%Search for SEC Filing on Google Icon
8/17/2021Caxton Corp39,586$0.54M0.4%N/A0.173%Search for SEC Filing on Google Icon
8/16/2021LMR Partners LLP31,300$0.43M0.0%N/A0.137%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.50,000$0.68M0.0%N/A0.219%Search for SEC Filing on Google Icon
8/16/2021venBio Partners LLC2,608,167$35.39M4.2%N/A11.428%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.125,000$1.70M0.0%N/A0.548%Search for SEC Filing on Google Icon
8/16/2021Schonfeld Strategic Advisors LLC25,700$0.35M0.0%N/A0.113%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP36,400$0.49M0.1%N/A0.159%Search for SEC Filing on Google Icon
8/16/2021Maven Securities LTD16,000$0.20M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.62,500$0.85M0.0%N/A0.274%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp4,803$65K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/13/2021Qube Research & Technologies Ltd24,255$0.33M0.0%N/A0.106%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.60,000$0.81M0.0%N/A0.263%Search for SEC Filing on Google Icon
8/12/2021Monashee Investment Management LLC140,000$1.90M0.2%N/A0.613%Search for SEC Filing on Google Icon
8/11/2021Ghost Tree Capital LLC100,000$1.36M0.4%N/A0.438%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Elevation Oncology logo
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
Read More on Elevation Oncology

Today's Range

Now: $1.40
Low: $1.39
High: $1.50

50 Day Range

MA: $2.48
Low: $1.26
High: $3.94

52 Week Range

Now: $1.40
Low: $1.20
High: $16.22

Volume

213,237 shs

Average Volume

343,623 shs

Market Capitalization

$32.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Elevation Oncology?

Elevation Oncology's top insider shareholders include:
  1. Global Strategic Fund I Venbio (Major Shareholder)
  2. Global Hc Fund Pte Vertex II (Major Shareholder)
  3. Yun-Lung Chen (VP)
Learn More about top insider investors at Elevation Oncology.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.